Lilly’s drug for early Alzheimer’s shows promising results
August 6, 2025Medical Communications, Research and Development Alzheimer's, Eli Lilly, Neurology, dementia
Eli Lilly (Lilly) has announced positive new data from the long-term extension of its phase 3 study, showing that Kisunla …
FDA grants orphan drug designation to relapsed or refractory multiple myeloma candidate
August 6, 2025Medical Communications, Research and Development Oncology, Sanofi, US Food and Drug Administration, myeloma
The US Food and Drug Administration (FDA) has granted orphan drug designation to SAR446523, Sanofi’s investigational monoclonal antibody developed for …
Polpharma Biologics and Fresenius Kabi partner to develop treatment for ulcerative colitis and Crohn’s disease
August 5, 2025Mergers and Acquisitions Corporate, Crohn’s disease, Fresenius Kabi, Gastrointestinal tract, Polpharma Biologics, ulcerative colitis
Polpharma Biologics has signed a global licensing agreement with Fresenius Kabi for the commercialisation of PB016, a proposed biosimilar to …
Freya Pharma launches phase 2 study of therapy for female sexual dysfunction
August 5, 2025Research and Development Female Sexual Interest/Arousal Disorder (FSIAD), Freya Pharma Solutions, Genito-Urinary system, sexual health
Freya Pharma Solutions has announced the initiation of a phase 2 study evaluating its Lybrido to treat female sexual interest/arousal …
Advarra appoints Brian Hart as chief technology officer
August 5, 2025Business Services, Technical Consultancy Advarra, Corporate, chief technology officer, digital solutions
Digital solutions company, Advarra, has named Brian Hart as chief technology officer, strengthening its leadership team. Hart brings more than …
Hansa Biopharma announces positive data for Duchenne muscular dystrophy gene therapy
August 4, 2025Research and Development Duchenne Muscular Dystophy, Hansa Biopharma, Rare Diseases, Sarepta Therapeutics, clinical trial, genetic disorder
Hansa Biopharma has announced encouraging results from its ongoing SRP-9001-104 trial, which is investigating the use of imlifidase as a …
Biocair expands globally with new Shanghai office
August 4, 2025Logistics & Distribution, Manufacturing and Production Biocair, Corporate, life sciences logistics
Life science logistics specialist, Biocair, has announced the opening of a new office in Shanghai, marking a significant expansion of …
Central nervous system cancer metastases – the evolution of diagnostics and treatment
August 4, 2025CERo therapeutics, Cancer, T cell, immunotherapy
The current forms of immunotherapy, how T cell therapy works and what the future holds
Five Facts about sleep and mental health
August 3, 2025Medical Communications Five Facts, Psychiatry, insomnia, mental health, sleep, sleep disorders, sleep health
1 Rapid Eye Movement (REM) sleep enhances creative thinking and helps the brain form connections between ideas, supporting mental wellbeing …
The Pharma Files: With Priyanka Hinton from CHASE
August 3, 2025Business Services, Recruitment CHASE, The Pharma Files
Pharmafile chats with Priyanka Hinton, Customer Solutions Director at Chase People about the best parts of her job and her …
A challenge we can no longer ignore: meeting the needs of people with Crohn’s Disease in the UK
August 3, 2025Research and Development Crohn’s disease, Immunology, Lilly UK, autoimmune disease, immunology
By Holly Thomas, Associate Vice-President Specialty Care at Lilly UK and Ireland Immunology care in the UK is at a …
Ryvu Therapeutics publishes research revealing potential drug combination for colorectal cancer
August 1, 2025Medical Communications, Research and Development Oncology, Ryvu Therapeutics, colorectal cancer
Ryvu Therapeutics has published new findings from its ONCO Prime target discovery platform in Scientific Reports. The study reveals a …
ESTEVE expands into US market with acquisition of Regis Technologies
August 1, 2025Mergers and Acquisitions Corporate, ESTEVE, Pharmacy, Regis Technologies, US pharma market, contract development and manufacturing organisation
ESTEVE (Esteve QuÃmica), based in Barcelona, Spain, has acquired Regis Technologies, a contract development and manufacturing organisation (CDMO) based in …
Richmond Pharmacology appoints Priscilla Ochuba as associate medical director
August 1, 2025Research and Development Contract Research Organsation, Corporate, Pharmacy, Richmond Pharmacology, associate medical director
Richmond Pharmacology has announced the promotion of Priscilla Ochuba to associate medical director, effective 1 August 2025. The move recognises …
Labguru and Titian Software rebrand as Cenevo to accelerate connected labs
July 31, 2025Analytical & Laboratory Services, Research and Development Cenevo, Corporate, Labguru, Laboratory management
Lab management companies, Labguru and Titian Software, have rebranded under a new unified name, Cenevo. This combines their solutions, Mosaic …
Hansa Biopharma bolsters leadership team with new executive appointments
July 31, 2025Research and Development Chief Human Resources Officer, Chief Legal Officer, Corporate, Executive Leadership Team, Hansa Biopharma, Vice President Corporate Affairs
Hansa Biopharma has announced three senior leadership appointments to support its global expansion as well as pre-commercial activities in the …
BioDuro and Atombeat partner to accelerate AI-powered peptide drug discovery
July 31, 2025Mergers and Acquisitions AI, BioDuro, Corporate, Devices
BioDuro and Atombeat have announced a partnership to launch an artificial intelligence (AI)-driven platform designed to accelerate peptide drug discovery …
Key strategies to foster digital transformation in the NHS
July 30, 2025Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Visions4Health, digital transformation, pharmacy
In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …
NICE approves AstraZeneca’s dual immunotherapy for advanced liver cancer
July 30, 2025Medical Communications, Research and Development AstraZeneca, NHS, National Institute for Health and Care Excellence, Oncology, dual immunotherapy, hepatocellular carcinoma, liver cancer
AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence (NICE) for its dual immunotherapy …
Clinisys acquires Orchard Software to expand laboratory informatics leadership
July 30, 2025Analytical & Laboratory Services, Mergers and Acquisitions, Research and Development Clinisys, Corporate, Francisco Partners, Orchard Software, laboratory informatics, laboratory information management systems
Clinisys has announced the acquisition of Orchard Software from Francisco Partners, strengthening its position in laboratory informatics. The strategic acquisition …
Latest content
FibroFind appoints Lee Borthwick as CEO
